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ABSTRACT OF CAPSTONE 
INCIDENCE OF NON-HODGKIN’S LYMPHOMA BY RESIDENTIAL 
PROXIMITY TO SUPERFUND SITES IN KENTUCKY: A 
MULTIVARIATE ANALYSIS 
 
Non-Hodgkin’s Lymphoma (NHL) is a category of cancers that arise from 
the lymphocytes of the immune system. The rates of NHL in the United States 
and Kentucky began to rise in the mid-20th Century, shortly after the 
manufacture, use, and disposal of numerous chemical substances began to 
increase during and after the Second World War. While the etiology of NHL is not 
fully known, there are several chemical substances for which evidence exists of a 
possible link between exposures and development of NHL and other cancers. 
Several of these substances are also present in sites within Kentucky designated 
by the US Environmental Protection Agency as hazardous waste sites under the 
Superfund program. The present investigation sought to determine whether 
residential proximity to Superfund sites in Kentucky was a significant risk factor 
for NHL. Geospatial coordinates for all Superfund sites in Kentucky were 
obtained, along with US Census 2010 population data at the census tract level, 
and de-identified data from the Kentucky Cancer Registry for all NHL cases 
between 1995 and 2012, including residential geospatial coordinates. Incidence 
data was calculated at the level of census tract, except for <5km buffer rings and 
5-10km buffer circles around each Superfund site, whose NHL incidence data 
was calculated separately. Residence within the <5km and 5-10km buffer zones 
were the exposure variables, and other potentially relevant covariates were 
considered for the models, and tested for multicollinearity and significance.  
Because of spatial autocorrelation of NHL incidence data and non-
stationarity uncovered during exploratory regression and diagnostics, 
geographically weighted regression was used in addition to ordinary least 
squares regression. Using the best-fitting models, it was determined that 
residence less than 5km and between 5-10km from the nearest Superfund site 
were both significant factors in elevated cumulative NHL incidence rates. The 
Beale Code for rural/urban characteristics of the census tract was another 
significant predictor, with more rural areas having higher NHL incidence rates. 
Directions for future research, public health implications, and potential strategies 
for distal and proximal interventions are presented based on the results of this 
study.   
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CHAPTER 1 
INTRODUCTION 
 
Background – Non-Hodgkin’s Lymphoma 
 
Non-Hodgkin’s lymphoma (NHL) is a category of cancers that arise from the 
lymphocytes (white blood cells) of the immune system. NHL can arise from B-cell, T-
cell, or natural killer (NK) lymphocytes, and is differentiated from Hodgkin’s lymphoma 
(also known as Hodgkin’s disease) by the absence of a particular type of abnormal cell 
called the Reed-Sternberg cell, which is present in Hodgkin’s lymphoma1. The incidence 
and prevalence of NHL far exceeds that of Hodgkin’s lymphoma in the United States 
(U.S.); in 2014, NHL accounted for 88.5% of all estimated new lymphoma cases, and 
was responsible for sixteen times more cancer deaths than Hodgkin’s lymphoma2-3. 
Lymphomas differ from leukemia, another type of cancer that can manifest in the 
lymphatic system, in that leukemia is a cancer of the blood-forming cells in bone 
marrow, which can develop into myeloid or lymphoid variants4. By contrast, lymphomas 
arise from the abnormal transformation and growth of already differentiated B-cells 
(and, less frequently, T-cells) in the lymphatic system, often resulting in solid tumors5. 
Different types of NHL are most often categorized by the types of cells affected, 
the location(s) of solid tumors, or both. Approximately 85% of NHL cases arise from B-
cells, 15% from T-cells, and less than one percent from NK cells6-7. The most common 
forms of NHL in the U.S. are the diffuse large B-cell lymphomas (approximately 33% of 
cases)8 and B-cell follicular lymphomas (approximately 20% of cases)6. The most 
common type of T-cell NHLs are peripheral T-cell lymphomas, which account for 
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approximately 14% of U.S. NHL cases6. Cases of NHL where tumors arise from lymph 
nodes or other lymphatic tissues such as the spleen or thymus are referred to as 
intranodal NHL, whereas extranodal NHL arises from lymphatic cells in other organs 
such as the small intestine, stomach, and skin9-10. Approximately 25% of U.S. NHL 
cases are of the extranodal type10. 
In 2012, NHL was the 8th most common cancer in the overall U.S. population, the 
6th most common cancer among males, and the 7th most common among females11. 
Males have a higher incidence rate for NHL compared to females in the U.S. (22.5 vs. 
15.3 per 100,000)11 and worldwide, for reasons that are not fully understood but which 
could involve protective effects from estrogen or other hormones in females12-13.  NHL 
incidence rates in the U.S. increased markedly during the middle of the 20th Century, 
before stabilizing in the mid-1990s but remaining among the highest in the world to the 
present day2,14-16. While most other forms of cancer either showed a decline in the 
incidence rate during the 20th Century, or an increase that could be directly tied to 
known causal factors (e.g. lung cancer and tobacco smoking) or improved screening 
and early detection, the increase in NHL incidence defies simple explanations. 
Therefore, the contribution of several factors including exposures from the external 
environment must be considered. 
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Figure 1: Hon-Hodgkin’s Lymphoma Incidence rate and death rate per 100,000, 
United States, 1975-2011 (Source: National Cancer Institute, Surveillance, Epidemiology, and End 
Results (SEER) Program2) 
 
 
Background – Hazardous Waste Management Practices: United States 
The demands of the Second World War (1939-1945) led to the proliferation of 
chemical investment and innovation in both Allied and Axis nations. This set up a 
postwar technological trajectory that led to the rapid expansion of fields such as 
petrochemicals, pesticides, and pharmaceuticals17. New products were being 
introduced to the market and into the environment before all the known and suspected 
human and environmental toxicities could be fully known. The first reports of human and 
aquatic toxicities from new agricultural pesticides, which had been originally developed 
as wartime agents, began emerging as early as the late 1940s18.  
In the early 1950s, at approximately the same time when NHL incidence began 
to increase in the U.S.19, new questions began to arise about the effects that 
widespread chemical usage, contamination, and waste disposal practices might be 
having on human health and the environment, and whether these might be contributing 
11 
 
to specific disease outcomes. The tremendous increase in the production and use of 
new and established chemical products following the Second World War led to the 
generation of both hazardous and non-hazardous waste streams at previously unseen 
levels, and led to greater potential for community or ecosystem exposures20.  One 
touchstone in the development of the modern grassroots American environmental 
movement was the publication of Silent Spring by Rachel Carson in 1962, which 
detailed the negative effects of non-selective pesticides on avian species21. 
The ways in which various jurisdictions and industries chose to deal with wastes 
frequently resulted in environmental costs being borne by the disadvantaged, minorities, 
and persons other than those in the generating industry or municipality22. Greater 
environmental consciousness and demands for justice led to federal standards as a 
baseline for state and local regulations, and the eventual establishment of the U.S. 
Environmental Protection Agency (EPA) in 1970. The Clean Air Act and Clean Water 
Act were the first major regulations adopted by EPA; however, solid waste and 
hazardous waste was considered a unique local problem that resisted federal regulation 
until 197623.  
The Resource Conservation and Recovery Act (RCRA) of 1976 set forth national 
standards for sanitary landfills and other disposal methods of municipal solid wastes, 
and “cradle-to-grave” transport, storage, and ultimate disposal of hazardous wastes24. 
However, while RCRA dealt with waste disposal and reduction practices going forward, 
it did not deal with past dump sites which could continue to affect their surrounding 
communities for decades23. The need for additional federal regulations to deal with past 
hazardous waste sites was vividly illustrated in the late 1970s by the Love Canal 
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disaster in Niagara Falls, New York and the discovery of the Valley of the Drums in 
Bullitt County, Kentucky25-26. 
The Comprehensive Environmental Response, Compensation, and Liability Act 
of 1980 (CERCLA) established mechanisms for determining which sites constituted the 
greatest threat to human health and the environment, and designated a tax on 
petrochemical industries to generate a trust fund known as “Superfund” to clean up 
these sites27. When potentially responsible parties could not be found, or did not have 
the resources necessary to adequately clean-up a site, money from the Superfund 
would be used to pay for these activities. In general, all sites on which CERCLA-
covered activities have occurred or are being investigated are known as Superfund sites 
and maintained in EPA databases, whereas the most hazardous sites requiring greater 
and long-term remediation activities are put on the National Priorities List (NPL) and are 
often additionally referred to as NPL sites28. As of 2015, there were a total of 234 
Superfund sites in Kentucky, twenty of which are currently or formerly designated as 
NPL sites. 
 
Statement of the Problem 
Long before the official designation of NPL and Superfund sites, both the 
research community and those who live near these sites wondered the extent to which 
human health effects might have resulted from exposures to materials at these sites. 
The public frequently submitted requests for “cancer cluster” investigations to the 
Centers for Disease Control and Prevention (CDC) around these sites, partially due to a 
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tendency among the public to attribute negative health outcomes to external 
environmental factors to a greater extent than the scientific community28-29. 
Nevertheless, there are also scientific reasons to investigate causality of 
environmental factors for health outcomes. Several contaminants present at Superfund 
sites are of special concern due to their persistence, bioaccumulation, acute toxicity, 
and likelihood of exposure due to localized accumulation30. However, multiple spatial 
and temporal issues complicate these investigations, such as on-site process variability, 
residential mobility, latency factors for chronic diseases such as cancer, geologic and 
meteorological variance, transformation of waste products over time, and delineation of 
exposure vs. non-exposure areas31. Because human exposures to environmental 
insults from Superfund sites are usually low-level and variable, most physiological-
based pharmacokinetic modeling strategies used in classical toxicology are not a good 
fit32. Furthermore, there are numerous possible confounders with environmental 
exposure outcomes research in human subjects, such as race, socio-economic status, 
along with smoking, diet, exercise, recreational activities, and occupational exposures 
which must be considered32. 
With these caveats in mind, it remains critically important to evaluate the 
potential causality of environmental factors in negative health outcomes, particularly 
those such as NHL whose increased incidence in the U.S. and several other developed 
nations tracks reasonably closely with the wider industrial use, disposal, and dispersion 
of chemical substances into the environment. 
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Purpose and Significance of the Study 
 
Kentucky has 20 NPL sites and 234 total Superfund sites, but to date no 
analyses with geospatial tools have been published on the possible relationship 
between health status and residential proximity to these sites. Kentucky is also 
presently ranked 47th nationally for overall health and is the state with the highest 
cancer death rate33. Though several studies have examined possible cancer clustering 
around hazardous waste sites, many used crude and relatively large areas of 
“exposure” and “non-exposure”, and were not able to demonstrate possible gradient 
effects. This study will use statistical and geospatial tools to model the extent to which 
residential proximity to Superfund sites in Kentucky might explain prevalence of NHL, 
while controlling for covariates.  
NHL was chosen as the outcome variable due to its possible association with 
environmental exposures, and its unique historic incidence trends in the United States. 
For the years 2007-2011, Kentucky was ranked 4th nationally for age-adjusted non-
Hodgkin’s lymphoma death rate34. The NHL rates in Kentucky also parallel the national 
and international Western trends of increased incidence in the mid-20th Century across 
all genders and age groups35, with the highest overall rates seen in white males8,35. This 
pattern is seen in both intranodal and extranodal forms of NHL, with extranodal NHL 
exhibiting similar demographic patterns to intranodal NHL9,36.  
Geospatial analysis tools can be used to determine potential gradient effects if 
data for both exposures and outcomes can be geocoded and modeled. Ultimately, if it is 
determined that residential proximity to NPL/Superfund sites increases NHL risk, and/or 
“hot spots” are uncovered, public health strategies for prevention and early detection 
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can be directed to these areas in order to save lives and prolong quality of life37. In 
addition, if these risks are demonstrated to disproportionately affect disadvantaged 
persons, the study can provide supporting evidence for programs designed to foster 
improvements in social justice and equality. 
The current study examined incidence rates from 1995 through 2012 (the most 
recent year from which full data was available) from the Kentucky Cancer Registry for 
all forms of non-Hodgkin’s lymphoma (NHL), intranodal and extranodal. While all types 
of NHL could have heritable and lifestyle factors for risk, they also have known or 
suspected etiologies from the external environment as described earlier.  
The goal of the project was to perform a spatial analysis to examine the 
relationship between NHL cancer incidence and proximity to hazardous sites. Data 
sources included the following: 
- US EPA Superfund location data for Kentucky. Geospatial coordinates are 
available for all twenty NPL sites in Kentucky. For the non-NPL sites, 113 of 
the 214 were unique, non-duplicative sites with geospatial coordinates 
available; thus, the total number of EPA sites available for inclusion is 133; 
- Kentucky Cancer Registry 1995-2012 case data for incidence of non-
Hodgkin’s lymphoma, intranodal and extranodal;  
- 2010 US Census demographic data at the census tract level. This is a unit of 
census data that can be tabulated while maintaining subject confidentiality. 
Census tracts represent between 1500 and 8000 people, and are intended to 
represent neighborhoods that are relatively stable and homogenous38. 
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From these data, the next steps were to use methods of geospatial analysis, 
modeling, and outcome measurement to determine whether a significant effect exists 
between residential distance from Superfund sites and the incidence of NHL. The 
software utilized included ArcGIS, SPSS, and SAS in addition to MS Excel. Results 
could have a significant impact on public health if local hot spot areas are found where 
beneficial activities could be focused, such as cancer screening, nutritional interventions 
that could reduce vulnerability to stressors39, or built environment interventions. 
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CHAPTER 2 
LITERATURE REVIEW 
 
The following review of the literature is a summary of key concepts foundational 
to understanding the types of health effects that can cluster near hazardous waste sites, 
the use of geospatial tools to investigate these clusters, and the possible environmental 
causes of non-Hodgkin’s lymphoma (NHL) and other cancer types.  It represents 
theoretical and empirical knowledge gathered from the disciplines of epidemiology, 
medicine, environmental health, geography, and governance. The works cited are 
collected from peer-reviewed journal articles, book chapters, conference papers, 
symposium proceedings, and governmental agencies. Because the first Superfund sites 
were designated by the US EPA in 1981, an examination was conducted of the 
literature from 1981 to 2015 in order to capture the earliest evaluations of possible 
health effects at these sites. The databases and sources used to identify the scholarly 
literature included EBSCO Academic Search Complete, NCBI PubMed, OCLC 
WorldCat, and LexisNexis. The key words and phrases for the searches included 
“Superfund”, “environment”, “cancer”, “geospatial analysis”, “lymphoma”, “non-Hodgkin 
lymphoma”, and “non-Hodgkin’s lymphoma”. A secondary review of writings referenced 
in the bibliographies of key works augmented the process. 
The literature review also focused on the most common types of cancer in the 
study population for which it was possible that environmental exposures could play a 
role in their initiation, promotion, or progression. The primary focus was on NHL, but 
literature on breast cancer and bladder cancer was also reviewed, as these were three 
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of the ten most frequent cancers in the population study basin. The other common 
cancer types in the study basin had predominant risk factors that were genetic or dietary 
(colon cancer), or suffered from the presence of overwhelmingly powerful confounders 
(e.g. lung cancer and high rates of smoking and indoor radon exposure, skin cancer and 
ultraviolet exposure). 
One of the first epidemiologic studies of a designated Superfund National 
Priorities List (NPL) site found that white males in the county hosting the site had a 
significantly elevated odds of developing bladder cancer (OR = 1.7, p<0.025)40. The 
authors measured exposure at county level, using national averages for comparison, 
and multiple outcomes were evaluated, so the elevated risk might have been due to 
multiple comparisons40.  A study from two Superfund sites in Texas found that residents 
designated as “high-exposure” due to residential proximity to the sites self-reported 
more neurological symptoms compared to low-exposure populations41, and that 
incidence rates for multiple cancers were elevated in the vicinity of a Department of 
Defense Superfund site in Massachusetts42. Serum immunoglobulin A levels were found 
in one meta-analysis to be consistently but not significantly elevated for residents near 
Superfund sites compared to matched controls at least five miles away from sites43. 
Another study estimated that multi-state Superfund site cleanup activities reduced the 
rate of infant congenital abnormalities by 20 to 25 percent for mothers who resided 5 km 
or less from the sites44.  
Studies have also examined the degree to which contaminants could migrate 
from Superfund sites into the surrounding ecosystems and communities. Tree bark 
samples within 10 km of an NPL site in Michigan showed 10- to 100-fold increases in  
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dichlorodiphenyltrichloroethane (DDT), hexabromobenzene, and polybrominated 
biphenyls compared to sites >10 km distant45. Passive sampling devices that mimicked 
the way living organisms accumulate lipophilic contaminants were deployed near an 
NPL site in Portland, Oregon, and contaminant levels that would result in an excess 
cancer risk greater than the EPA limit of 1x10-6 were found46. Residents near former 
uranium mining NPL sites had drinking-water ionizing radiation levels that exceeded 
public limits47. Researchers have also investigated social justice concerns with the siting 
of Superfund/NPL sites and found that poor and/or minority populations tend to be 
disproportionately affected48-52.    
The addition of geospatial information and tools in public health research have 
increased precision for examining spatial patterns within data, understanding 
relationships between outcomes and environmental variables, and inferring exposure 
patterns53. When precise address information is available for cases, geospatial analysis 
can provide sharp, precise boundaries of a cluster or area of exceedance to most 
efficiently deploy public health resources54. As evaluated areas get smaller (e.g. county, 
census tract, census block, geospatial coordinates), there is less variability in 
exposures, and ecological fallacy becomes less likely55. 
A geographic distribution analysis showed that blood levels of dieldrin (an 
organochlorine insecticide) increased by 1.6 ng/g for each one mile of closer residential 
proximity to a Superfund site in Maryland56. Another study of an NPL site contaminated 
with polychlorinated biphenyls (PCBs) found that residential proximity to the site was not 
a significant factor in cord serum PCB levels, but being born before or during dredging 
activities to remove PCBs from the site was significant57. Geospatial analysis has also 
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been used to identify clusters of childhood cancer near NPL sites in Dade County, 
Florida58, very-low birth weight near multiple NPL sites in Harris County, Texas59, and to 
investigate and confirm the unequal burden of NPL/Superfund sites among specific 
racial, ethnic, and socioeconomic demographics60-64.  
Outside the context of U.S. Superfund/NPL sites, exposures to e-waste 
dismantling sites in China at the village level were found to significantly elevate serum 
levels of thyroid-stimulating hormone and polybrominated diphenyl ethers, along with 
micronucleated binucleated cells65. In Taiwan, spatial autocorrelation analysis identified 
hot spots for various cancers in females in areas with high levels of environmental 
exposures to arsenic, nickel, and chromium66. And, in Australia, excess cancer risk and 
elevated soil arsenic from historic gold-mining activities were both found in economically 
disadvantaged areas67. 
Some primary and secondary contaminants frequently found at Superfund sites 
are suspected of initiating or promoting specific types of cancer such as breast, bladder, 
and NHL. Superfund site contaminants were shown to initiate or promote breast 
tumorigenesis through endocrine disruption68. Organochlorine compounds such as 
PCBs and DDE can act as estrogen mimics and partition into adipose tissues69-70. 
Organic solvents such as halogenated hydrocarbons and aromatic amino/nitro 
compounds exhibit mammary tumorigenic activity in rodent models71, and women who 
were occupationally exposed to solvents prior to first full-term birth had a significantly 
elevated breast cancer risk72. Additional animal studies have revealed more than 200 
chemicals and heavy metals that were mammary carcinogens or estrogen mimics73-74.  
21 
 
While the predominant risk factor for bladder cancer is smoking, accounting for 
approximately 50% of all cases75, environmental exposures to aromatic amines and 
polycyclic aromatic hydrocarbons are also risk factors for bladder cancer76-79. Arsenic 
that leaches into drinking water is another known bladder cancer risk factor, though the 
mechanisms are not well understood80. 
NHL incidence rates in the United States increased dramatically during the 
middle of the 20th Century and plateaued in the mid-1990s, but incidence rates still 
remain well above the levels seen prior to the post-Second World War chemical age. 
Persistent organochlorine compounds that became prevalent in the early- and mid-20th 
Century have been suspected as a causal factor, and numerous studies have shown 
associations between these compounds and NHL81-88. Meta-analysis of multiple case-
control studies has demonstrated a significant association between occupational 
exposures to pesticides and NHL89. Non-occupational exposures to two specific types of 
organochlorines, chlordanes and DDT, have been repeatedly associated with NHL in 
multiple studies89-93. Occupational exposures to pentachlorophenol has been associated 
with increased risk of NHL94. Polychlorinated biphenyls (PCBs) are another broad 
category of organochlorines that are persistent organic pollutants with high patterns of 
usage in the early 20th Century, and which show consistent causal associations with 
NHL83,95-97.  
Other chemicals that have been positively associated with NHL and which can be 
present at Superfund sites include phenoxy herbicides87,98, carbamate insecticides87, 
organophosphorus insecticides87, benzene and benzyl compounds99-101, 
trichloroethylene16, perchloroethylene102, polychlorinated dibenzo-p-dioxins and 
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dibenzofurans103-104, 1,3-butadiene105, cadmium106, and high nitrate levels in community 
water supplies107. The incidence and mortality rates of NHL were elevated for persons 
with non-occupational exposures to herbicides108. Elevated risk of NHL was also found 
in residents living near the Italian equivalent to NPL sites109, residential areas where 
exposures to traffic noise consistently exceeded 65 decibels110, lumber and wood 
products facilities111, pulp and paper industries112-113, copper smelters113, refineries that 
emit lead and cadmium114, and residences where geothermal hot water is used115.  
Numerous mechanisms have been proposed for how environmental exposures 
could lead to increased rates of NHL. Immune system suppression, which can be 
triggered by xenobiotics, is one of the primary known risk factors for NHL95,116-118. 
Widespread exposures to lymphomagenic substances can trigger immunosuppressive 
conditions36. Conversely, persons with a history of allergies, other hyperimmune 
disorders, or asthma appear to have a reduced risk of developing NHL119-121. 
Overexpression of cellular protein Exportin-1 which mediates the transport of other 
proteins between the nucleus and cytoplasm has also been associated with increased 
risk of NHL, and Exportin-1 inhibitors have shown early promise in treatment of NHL122. 
While the Human Immunodeficiency Virus (HIV) has been suspected as one of 
the causal factors in rising NHL incidence due to its profound immunosuppressive 
effect, NHL incidence rates have also risen among the HIV-uninfected123-124. In addition, 
HIV and the associated illness of Acquired Immune Deficiency Syndrome (AIDS) did not 
rise to a level detectable by public health surveillance in the U.S. until 1981125, and the 
NHL incidence spike started decades earlier.  
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Some xenobiotics can have a directly toxic effect on the hematopoietic system, 
which can lead to various forms of lymphoma or leukemia. Examples of this include 
benzene126, cadmium127, and lead128. Another possible mechanism of toxicity is the 
generation of reactive oxygen species following xenobiotic exposures, resulting in 
damage to cellular DNA129, or chronic antigen stimulation resulting in inflammatory 
cascades36. Alternately, the site contaminants themselves can be transformed into toxic 
free radicals capable of direct cytotoxicity. Two examples of this are the transformation 
of pentachlorophenol into free radicals that can persist in the environment for 
decades130, and the generation of environmentally persistent free radicals that can 
inhibit cytochrome p450-based xenobiotic metabolism131.  An Algerian study indicated 
that pesticide exposures altered the ratio of T-helper 1 to T-helper 2 cells via 
proliferation of nicotinamide adenine dinucleotide phosphate hydrogen (NADPH), 
significantly increasing the risk of NHL132.  
It is also probable that gene-environment (GxE) interactions lead to the 
development of some NHL cases133-134. Multiple subtypes of  NHL are associated with 
the t(14;18) chromosomal translocation and oncogenic activation, which can be 
triggered by environmental toxicants129,135-138. For some cases of NHL, the relationship 
between organochlorine exposures and outcome appears to be modified by variations 
of genes for numerous interleukins139. Genetic variance in xenobiotic metabolism and 
DNA repair pathways have also been shown to likely modify the relationship between 
NHL and chlorinated hydrocarbon exposure140.  Single-nucloetide polymorphisms in the 
Ataxia-Telangiectasia Mutated and Tumor Necrosis Factor-alpha loci are associated 
with elevated risk of  multiple B-cell NHL subtypes141-142. 
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For the twenty sites in Kentucky on the National Priorities List, information on the 
contaminants of concern at each site is available from the US Library of Medicine 
TOXMAP webpage143. The following seven categories of contaminants associated with 
increased risk of NHL were present at Kentucky NPL sites: benzene and benzyl 
compounds (15 of 20 NPL sites, 75%), lead (14/20, 70%), polychlorinated biphenyls 
(11/20, 55%), cadmium (9/20, 45%), trichloroethylene (7/20, 35%), organochlorines 
other than PCBs (6/20, 30%), and perchloroethylene (2/20, 10%). Information on 
contaminants of concern was not available for the non-NPL Superfund sites in 
Kentucky. 
In summary, the literature review shows that NHL incidence in the U.S. and 
Kentucky has risen in a temporal pattern that appears commensurate with the greater 
use and dispersion of multiple chemical substances into the environment. The literature 
also demonstrated there are feasible ecological and biological mechanisms by which 
substances from Superfund and other hazardous chemical sites can enter the 
community environment and exert toxic effects, including those that could trigger NHL. 
The methodology in the next chapter details the research strategy employed to 
investigate whether residential proximity to Superfund sites in Kentucky could be at 
least partially responsible for an increased incidence of NHL. This question has not 
been previously investigated, and the results could point to the need for greater 
screening, awareness, and other interventions that might save lives, prolong the quality 
of life, or increase environmental justice in affected regions. 
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CHAPTER 3 
METHODOLOGY 
 
This is an observational population study, using data from three sources, to 
examine the relationship between the residential proximity of patients diagnosed with 
non-Hodgkin’s lymphoma (NHL) to environmentally hazardous sites and the likelihood 
for developing NHL cancer, while controlling for individual characteristics. The 
hypothesis is that residential proximity to Superfund sites in Kentucky is a significant 
factor in an increased risk of NHL, even after adjusting for other covariates.  
 
Data Sources 
The NHL cancer data from the Kentucky Cancer Registry (KCR) was obtained for 
18 years, from 1995 to 2012, following approval of the University of Kentucky 
Institutional Review Board (Appendix 1). All individual identifying information was 
removed from the data by KCR before it was given to investigators, other than the 
geospatial coordinates for their residential address. Each patient was a assigned a 
random unique identification number, which was used to unduplicate the data to retain 
the first cancer diagnosis and eliminate any subsequent ones.  
The environmental exposure data came from the US EPA Superfund website for 
Region 4 (which includes the state of Kentucky)146. The EPA sites were categorized 
based on whether they were presently or formerly on the National Priorities List, and the 
geospatial coordinates of the area where the contamination occurred or is occurring. In 
Kentucky, there are 20 current or former NPL sites, all of which had full geospatial 
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coordinates available. There were a total of 214 additional, non-NPL Superfund sites, 
for which only 113 had geospatial coordinates available (Figure 2). The 133 total sites 
with geospatial data were treated as point-sources of environmental exposure.  
 
 
Figure 2. Location of 133 NPL/Superfund sites in Kentucky for analysis 
 
 
Census tract Tiger file was obtained from the 2010 US Census website. There 
are a total of 1,115 census tracts in Kentucky of which 734 had reported cases of NHL 
between 1995 and 2012.  
 
Independent Variables 
The independent variables include categorical residential proximities to 
Superfund sites and individual patient data from the KCR. The 2010 census tract counts 
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of all people by gender and age categories (5-year increments) was used for the 
computation of age-standardized incidence rates (e.g., overall, for males, for females). 
The patient level data from the KCR included NHL cases with both types of this 
cancer: intranodal and extranodal. Other variables available for the NHL cases included 
sex, race, ethnicity, tobacco usage (categorical), age at diagnosis, family history of 
NHL, county of residence, Appalachia region designation, and Beale Code that 
categorizes areas by their level of urbanization. The exposure, or patient’s residential 
proximity to Superfund sites, was measured by an ordinal variable with three categories: 
0= exposure beyond 10 km, 1= exposure within 10 km, but beyond 5 km, and 2= 
exposure within a radius of 5 km. For the multivariate analysis the exposure variable 
was recoded into two dummy variables; exposure within 5km (yes/no), and exposure 
between 5km and 10 km (yes/no), with exposure beyond 10km as the reference group 
for the analysis.  
 
Dependent Variables 
The dependent variables in this study are the age adjusted rates: overall, by 
gender, and by cancer type (extranodal, intranodal). The age standardization of rates 
were computed  using the direct method with the 2000 US Census population as a  
weighting factor, per current recommendations from the Centers for Disease Control 
and Prevention144-145. Table 1 shows the crude rate for NHL incidence in Kentucky, 
1995-2012, the age-adjusted rate, and the weighting factors applied. 
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Table 1: Weighting Factors for Age Standardization of Kentucky NHL Data, 1995-
2012, based on 2000 US Census 
Age 
Group 
Population 
(A) 
Number of NHL 
cases 
(B) 
Age-Specific NHL 
incidence  Rate 
(per 100,000) 
(C) 
Weights for 
2000 U.S. 
Standard Pop. 
(D) 
Weighted Rate 
(E) 
0 – 9 565255 61 10.79158964 0.141668548 1.528828834 
10 – 19 580949 127 21.86078296 0.145200521 3.174197075 
20 – 29 575264 221 38.41714413 0.131007086 5.032918105 
30 – 39 566331 583 102.9433317 0.151805676 15.62738206 
40 – 49 614893 1300 211.4188973 0.153968555 32.55186211 
50 – 59 607482 2392 393.7565228 0.111169775 43.77382405 
60 – 69 436630 3546 812.1292628 0.073057233 59.33191678 
70+ 392563 6143 1564.844369 0.092122607 144.1575428 
Total 4,339,367 14373 331.223425 1.00000 305.1784718 
Note: C=B / A; E=C*D 
 
The patient data was geocoded at census tract level; each census tract has a 12-
digit Federal Information Processing Standards (FIPS) Code147. Each case was placed 
wtihin a census tract, based on its geographic coordinates. The age-adjusted incidence 
rates of NHL were estimated for each exposure area, and for all census tracts outside 
the exposure areas, by using the 2010 Census census tract population as the 
denominator and the 1995-2012 NHL cases as the numerator, along with the 2000 US 
Standard population weighting factors. Specifically, the exposure areas were developed 
in ArcMap by drawing 5km and 10km buffers around each Superfund site and by 
identifying which census tracts and how much of their geographical areas fall within 
each exposure area. When buffers of neighboring Superfund sites intersected, they 
were dissolved into a single area of exposure, and the perimeter of all of the conjoined 
buffers became the boundary of the newly created exposure areas. Therefore, the 5km 
exposure areas have different sizes and shapes, including different number of census 
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tracts (or fragments of census tracts), and different numbers of Superfund sites within 
their boundaries.  
There were 71 areas within 5km of one or more Superfund sites, and each was 
assigned a unique ID. The 5km dissolved areas were removed (erased) from the 10km 
disolved areas, to form a secondary area of exposure (that sometimes looks like a 
donut) that was outside 5km of any Superfund site, but within 10km of at least one 
Superfund site. There were 45 areas of exposure between 5km and 10km away from 
any Superfund site; these areas were also assigned a unique ID. Finally, the remaining 
areas of the state, outside the 5km and 10km exposure areas, formed the third area of 
interest, the “unexposed” areas of the state, for which the incidence rates were 
computed at census tract level.  
To account for the distribution of population across the census tract fragments 
that fall within the 5km radius, between 5km and 10km “donut”, and beyond 10km, the 
proportion of each census tract that falls within a specific area of exposure was 
calculated. This calculated percentage was applied to the computation of the census 
population with specific characteristics (e.g., in terms of age and gender) within each 
fragment. A multiple exposure variable was created to account for the differences in the 
number of Superfund sites within the boundaries of different exposure areas.   
The numerator in the formulae for the age-adjusted rates was the number of 
cases with specific gender and age characteristics within each exposure area, and was 
calculated using the spatial location of each patient’s residence. Specifically, cases 
were placed into exposure categories based on whether their residential geospatial 
coordinate was within a 5km exposure area, a 5km to 10km “donut” exposure area, or 
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outside all of the exposure areas. Cases with residence located outside of all the 
exposure areas (e.g. lived more than 10km from any Superfund site) were classified as 
“unexposed”. At the latitude where Kentucky is located on the globe, 103.44 km equals 
one decimal degree.  
Univariate analysis included counts, proportions, means, medians and standard 
deviations for the following characteristics by level of analysis: 
a) For the patient or case level data, univariate analysis is provided for the 
following variables: gender, race, age at diagnosis, current tobacco use, 
tumor type, family history of NHL, residence in Appalachian regions, Beale 
Code urban or rural designation, and residential proximity to the nearest 
Superfund site.  
b) For the census tract level, univariate analysis is provided for the following 
variables: number of NHL cases, total population, and number of Superfund 
sites within the tract. 
Bivariate analysis was conducted using statistics such as chi-square tests, t-
tests, and the one-way analysis of variance (ANOVA). The underlying population was 
naturally skewed, but the sampled data set was large enough to offset this.   
Spatial regression analyses were performed for each dependent variable. The 
dependent variables were the incidence rates of NHL at the census tract level, overall 
and stratified by gender and SEER tumor type classification. In each of these regression 
models, the principal predictor variable was the type of exposure area (within 5km, over 
5km to 10km, and over 10km) measuring the residential proximity to Superfund sites as 
a proxy for possible exposures to contaminants at these sites. Other independent 
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variables that were identified in the literature as possibly related to NHL incidence and 
also considered for the regression models were smoking status and family history of 
cancer. Race was not included in the analyses due to the small number of cases that 
were of other race than Caucasian/White.  
Due to the relatively large size of the study basin (the entire Commonwealth of 
Kentucky), and its underlying regional, cultural, and socioeconomic diversity, it was 
determined that Geographically Weighted Regression (GWR) would most likely be 
necessary for analysis. With large study areas such as an entire state or region, it is 
often not prudent to use global or aspatial regression because the impact of covariates 
can vary across the area148-149. Diagnostic tools were used on the data to detect the 
presence of spatial autocorrelation and clustering, and thus to confirm the choice to use 
GWR in addition to ordinary least squares regression modeling. 
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CHAPTER 4 
RESULTS 
 
The results of the descriptive analyses are shown in Table 2 for case data. There 
were a total of 14,373 new NHL cases in Kentucky between 1995 and 2012. Per the 
2010 US Census, Kentucky has a total of 1,115 census tracts within its 120 counties. 
While 82.3% of the NHL cases could be assigned to census tracts based on high-quality 
residential geospatial coordinates, for the remaining 17.7% the geospatial coordinate 
was the centroid of their residential ZIP code. This often occurs when a case lists their 
address as a rural route or post-office box. 
 
Univariate Analysis 
The caseload of 14,373 patient population included 51.5% males, 94.7% of all 
cases were white, and 39.1% were current users of tobacco products. Intranodal NHL 
accounted for 70.8% of all cases, 71.7% of male cases, and 69.9% of female cases. 
Only 3.7% of the cases had a known prior family history of NHL. For most cases, there 
was either no prior family history (52.2%) or an unknown prior family history (44.1%). 
Only 28.1% of cases lived in counties that were part of the designated region of 
Appalachia, and only 9.6% of cases lived in Beale Code designated rural regions. Of all 
cases that were of other than white race, only 0.6% were Hispanic or Latino of any race 
(data not shown) and 4.4% were African American; due to the low proportion of non-
white cases, analyses by race could not be completed. In accordance with national NHL 
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statistics, 67.4% of all diagnoses occurred in patients age 60 or older. Nearly 30 percent 
of cases lived within 5km of a Superfund site.  
 
Table 2: Descriptive Statistics for the Patient Data (N=14,373) 
 
Demographic Variable 
 
 
Category 
 
Number 
 
% of Total 
Gender Female 6978 48.5 
Male 7395 51.5 
 
Race 
White 13617 94.7 
Black 632 4.4 
Other/Unknown 124 0.9 
 
 
 
Age at Diagnosis 
 
 
0-9  61 0.4 
10-19 127 0.9 
20-29  221 1.5 
30-39  583 4.1 
40-49  1300 9.0 
50-59 2392 16.6 
60-69 3546 24.7 
70 and above 6143 42.7 
Tobacco Use Non-User 5715 39.8 
Cigarette Smoker 5237 36.4 
Cigar-Pipe Smoker 138 1.0 
Smokeless Tobacco User 136 0.9 
Multiple Types of Tobacco Used 116 0.8 
Not Recorded/Unknown 3031 21.1 
Tumor Type Intranodal NHL 10181 70.8 
Extranodal NHL 4192 29.2 
Family History of NHL No  7495 52.2 
Yes 533 3.7 
Unknown 6345 44.1 
Appalachia Region No 10337 71.9 
Yes 4036 28.1 
Beale Code Classification Urban 12997 90.4 
Rural 1376 9.6 
Residential Proximity to 
Nearest Superfund site  
<5 kilometers 4225 29.4 
5-10 kilometers 3570 24.8 
>10 kilometers 6578 45.8 
 
 
The total number of new cases per year showed an upward trend between 1995 
and 2007, after which rates plateaued but stayed elevated through 2012 (Figure 3). The 
highest total number of cases was in the last year of collected data (2012), and the 
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lowest number was in the first year collected (1995). When cases were stratified by race 
into white and non-white categories, this trend was more pronounced in non-white 
populations (Figure 4), though the peak year for non-white NHL cases was 2009. 
 
 
 
 
Figure 3. New non-Hodgkin’s Lymphoma Cases in Kentucky, 1995-2012 
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Figure 4. Number of new non-Hodgkin’s Lymphoma Cases in Kentucky, 
1995-2012, by Year and by Race 
 
 
 
Figures 5 and 6 show the distribution of cases by age categories, separated by 
gender and tumor classification  of intranodal (SEER classification 33041) and 
extranodal (SEER classification 33042) types. As expected, an age-related increase in 
NHL incidence was observed for both males and females, and for both SEER 
classifications, with a sharp increase in NHL for females ages 60-69. Intranodal NHL 
cases were consistently more than double the extranodal cases, across all age groups, 
and both showed sharp increases in the 60-69 age group.  
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Figure 5. NHL by Sex and Age at Diagnosis 
 
 
 
Figure 6. NHL by SEER Classification and Age at Diagnosis 
 
 
Univariate analysis at the census tract level is summarized below. The mean 
population per 2010 Census tract in Kentucky was 4104.8 (standard deviation 1721.0), 
with a median value of 3920. The number of NHL cases per 100,000 in each census 
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tract had a mean value of 209.8 (standard deviation 335.7), and a median value of 28.5. 
It is apparent that some influential census tracts are driving the mean number of NHL 
cases higher, as evidenced by the stark difference between the mean and median 
values. Eighty-seven percent of all census tracts in Kentucky did not have a Superfund 
site within their borders, and the remaining 13% had between one and five sites per 
tract.  
 
Bivariate analyses 
Table 3 presents descriptive analyses for gender, race, residence in Appalachian 
regions, Beale Code, family history of NHL, primary SEER tumor type, and tobacco use, 
stratified into three categories of residential proximity to the nearest Superfund site.  
Although analyses by race were not conducted due to the low proportion of non-white 
cases, it is worth mentioning that non-white NHL patients were more likely to live within 
5km of the Superfund sites, whereas residents of Appalachia and Beale Code 
designated rural areas were less likely to live near them. These results are not 
surprising given the distribution of the Superfund sites shown earlier in Figure 2; note 
that there is a dense concentration of sites in the area of the state with the highest 
percentage of African-American residents, and relatively few sites in the eastern and 
southern regions of Kentucky that are designated as Appalachian, and more likely to be 
classified as rural. Significant differences in categorical percentages also exist for 
tobacco use among cases, and in family history of NHL. The percentage of NHL cases 
with no family history of NHL, or without a known family history, were significantly higher 
for the cases residing within 5km of Superfund sites.  
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Table 3: Bivariate Analysis for the Case Data by Exposure 
Demographic Variable Residential Proximity to Nearest 
Superfund/NPL Site 
Chi-square 
value (df) 
P-value
<5 km 5-10 km >10 km 
Gender Male 2170 (29.4%) 1793 (24.2%) 3432 (46.4%) 3.54 (2) .170 
Female 2055 (29.4%) 1777 (25.5%) 3146 (45.1%)   
Race White 3826 (28.1%) 3400 (25.0%) 6391 (46.9%) 234.04 (4) <.001 
Non-white 351 (55.4%) 133 (21.0%) 150 (23.7%)   
Appalachia No 3459 (33.5%) 3070 (29.7%) 3808 (36.8%) 1198.44 (2) <.001 
Yes 766 (19.0%) 500 (12.4%) 2770 (68.6%)   
Beale Code 
Classification 
Urban 4157 (32.0%) 3497 (26.9%) 5343 (41.1%) 1186.59 (2) <.001 
Rural 68 (4.9%) 73 (5.3%) 1235 (89.8%)   
Family 
History of 
NHL 
Yes 133 (25.0%) 130 (24.4%) 270 (50.7%) 9.94 (4) <.001 
No 2234 (29.8%) 1817 (24.2%) 3444 (46.0%)   
Unknown 1858 (29.3%) 1623 (25.6%) 2864 (45.1%)   
SEER Type Intranodal 2969 (29.2%) 2547 (25.0%) 4665 (45.8%) 1.12 (2) .572 
Extranodal 1256 (30.0%) 1023 (24.4%) 1913 (45.6%)   
Tobacco Use 
Status 
Non-User 1716 (30.0%) 1479 (25.9%) 2520 (44.1%) 12.49 (4) .014 
Tobacco User 1653 (29.4%) 1347 (23.9%) 2627 (46.7%)   
 Not recorded  856 (28.2%) 744 (24.5%) 1431 (47.2%)   
 
 
Because census tracts can vary in both population and area, it is important to 
compute and use in the analyes the rate of NHL incidence per 100,000 persons, rather 
than the number of cases. Also, to account for aging effects on health and for the  
differences in the number of and  ages of residents across block groups, data was age-
adjusted. The cumulative incidence rates for NHL per 100,000 persons from 1995-2012 
in each census tract, age-adjusted using the 2000 US Census standard population, are 
depicted in Figure 7. Exposure and age-adjusted outcome data was aggregated at the 
levels of census tract, plus 5km buffers and 5-10km buffers around Superfund sites that 
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could contain parts of several census tracts. There are some areas of noticeably higher 
NHL incidence, scattered mostly in the western and south-central regions of Kentucky. 
 
 
 
 
 
One-way analysis of variance (ANOVA) was used to compare the average age-
adjusted cumulative NHL incidence  rates  by exposure groups (<5km, 5-10km, over 
10km). The incidence rates (overall, for males, females, for each SEER tumor 
classification, and for each SEER classification by gender) were significantly greater 
within 5km exposure areas than in the other two groups; further, the rates within 5km 
and 10km from the Superfund sites were significantly greater than the rates in the 
unexposed areas. In almost all strata, the means in the unexposed group are 
significantly lower than those in the exposed groups; at a significance level of p<0.05, 
Figure 7. Overall Cumulative NHL Incidence Rate per 100,000 People (1995-2012) 
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the only category in which the exposed and unexposed group NHL rates did not differ 
significantly was for the average incidence rate for the intranodal NHL in females 
(p=.064) . The data reflects the national trends, in that the male patients have a higher 
incidence rate than females for both intranodal and extranodal NHL (Table 4). 
 
Table 4: Age-Adjusted 1995-2012 Cumulative NHL Incidence Rates by Exposure 
Group 
 Age-adjusted NHL  
Incidence Rates 
Incidence Rate by Exposure Group  
Mean (std dev) 
ANOVA 
  <5km 
 
5-10km >10km F 
statistic 
p-
value 
Overall  457.0 (244.7) 308.6 (100.6) 290.9 (215.7) 17.8  <.001 
Gender Male 542.4 (341.2) 338.3 (113.3) 325.8 (249.5) 21.6 <.001 
Female  382.9 (240.2) 285.3 (116.7) 262.4 (303.6) 5.1 .006 
SEER 
Type 
Intranodal 323.4 (200.2) 218.7 (73.3) 208.5 (180.6) 12.3 <.001 
Extranodal 133.7 (82.8) 89.9 (49.6) 82.5 (76.6) 13.4 <.001 
Gender 
* SEER 
Type 
Intranodal -Males 384.1 (294.8) 239.7 (89.6) 235.8 (196.6) 15.8 <.001 
Intranodal - Females 267.7 (215.1) 202.4 (84.6) 185.9 (281.1) 2.8 .064 
Extranodal - Males 158.3 (154.3) 98.6 (60.2) 90.0 (102.1) 12.3 <.001 
Extranodal - Females 115.2 (83.5) 82.8 (60.3) 76.5 (97.4) 5.0 .007 
 
 
In addition, independent samples t-tests were used to compare the mean age-
adjusted incidence rates between Appalachia and Non-Appalachia regions (Table 5). 
None of the incidence rates were significantly different between Appalachia and non-
Appalachia. This finding is important because, for most types of cancer, Appalachia is 
generally known to have significantly higher incidence rates. 
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Table 5: Age-Adjusted 1995-2012 Cumulative NHL Incidence Rates by Region 
 Age-Adjusted NHL 
Incidence Rates 
Mean Number of Cases  (std dev) Independent t-test  
Appalachia Non-Appalachia T-statistic p-value 
Overall  305.8 (184.0) 308.0 (261.2) -0.137 .891 
Gender Male 338.1 (275.4) 350.9 (249.5) 0.654 .513 
Female  283.3 (388.3) 268.4 (203.6) -0.676 .499 
SEER 
Type 
Intranodal only 222.4 (226.0) 217.1 (142.5) -0.393 .695 
Extranodal only   85.6   (79.8)   88.7   (75.4) 0.533 .594 
Gender * 
SEER 
Type 
Intranodal for Males 246.0 (219.6) 251.4 (197.7) 0.344 .731 
Intranodal for Females 202.3 (371.2) 188.6 (167.6) -0.675 .500 
Extranodal for Males   92.1 (103.3)   99.5 (110.2) 0.921 .357 
Extranodal for Females   81.0 (102.1)   79.8   (89.9) -0.172 .863 
 
 
Multivariate Analyses 
Spatial regression models were developed using the ArcMap software. For 
multivariate analysis, the exposure was measured with two dummy variables: exposure 
within 5km (yes=1/no=0), and exposure between 5km and 10km (yes=1/no=0), with 
exposure beyond 10km as the reference group for the analysis. Because the outcome 
and exposure data have a spatial dimension, it was important to determine whether 
spatial autocorrelation existed in the data. Exploratory regression and diagnostic tests 
were conducted to verify whether geographically weighted regression (GWR) would be 
necessary, or if standard ordinary least squares (OLS) regression modeling alone would 
suffice. Testing was also performed to determine whether predictor effects on the 
outcome were consistent across the studied area (stationarity), as an additional 
determination whether GWR would be necessary. 
Data characteristics from the individual level such as race, smoking status, and 
family history of NHL, which were compared across exposure categories in bivariate 
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analysis, were not available at the census-tract level and thus were not included in 
multivariate models. Two other individual-level data characteristics (gender and SEER 
tumor type) were controlled at the multivariate level by calculating age-standardized 
NHL incidence rates by gender and SEER tumor type, along with the overall rate. 
Exposure categories, Appalachian status, Beale Code, and a series of population and 
housing characteristics at the census tract level were considered for inclusion in 
multivariate models. Multicollinearity coefficients obtained during the exploratory 
regression steps showed that most of the population and housing characteristics at the 
census tract level exhibited significant multicollinearity and could not be included in the 
same model (Variance Inflation Factors >10). Furthermore, none of these tract-level 
characteristic variables had a significant effect on NHL incidence rates, so they were not 
considered for subsequent regression modeling. There was no multicollinearity between 
Appalachian status and Beale Code, so both variables were considered for regression 
modeling.  See Appendix 2: Exploratory Regression Output. 
The Global Moran’s I tool in ArcGIS was used to quantify the presence of spatial 
autocorrelation among residuals (Table 6). Overall rates were examined, along with 
rates by gender, SEER tumor classification, and by both gender and SEER 
classfication.  All showed significant and positive Z-scores, and thus significant 
autocorrelation and clustering of similar residual values.  
The Anselin’s local Moran’s I tool (also known as the Local Indicators of Spatial 
Association or LISA) in ArcGIS also confirmed the presence of autocorrelation, 
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Table 6: Tests for Spatial Autocorrelation of Outcome Data Using Global Moran’s I 
Stratum Global Moran’s I Z-score P-value 
Overall 0.033592 7.303229 <.001 
Intranodal 0.023284 5.168179 <.001 
Extranodal 0.058884 12.61339 <.001 
Male 0.038898 8.384161 <.001 
Intranodal 0.028624 6.203308 <.001 
Extranodal 0.051379 11.03733 <.001 
Female 0.02186 5.121112 <.001 
Intranodal 0.010848 2.720941 0.007 
Extranodal 0.053696 11.53571 <.001 
 
 
clustering, and spatial outliers. Figure 8 depicts, for the overall NHL incidence data, the 
existence of multiple geographic areas where significant high and low clustering of NHL 
rate data exist, along with areas where significant spatial outliers occur (e.g. low-NHL 
local areas adjacent to high-NHL areas, or vice versa). The pattern is similar to what 
was observed in the overall incidence data from Figure 7, with high clusters in the 
western and central regions, and low clusters and high-low outliers predominate in the 
eastern and southern regions that are also designated as Appalachia. 
The clustering and outlier areas of NHL incidence data stratified by gender, 
SEER classification, and both gender and SEER classification are collectively depicted 
in Figures 9 through 11. Each of these maps also confirm that spatial autocorrelation 
and clustering exist in this data. For the most part, these maps show a profile similar to 
the overall NHL incidence data, with the notable exception that a cluster of extranodal 
NHL incidence in females was observed in the Appalachian region of Ashland-Boyd 
County in northeastern Kentucky, an area with abundant petrochemical industries and 
Superfund sites. 
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Figure 8. Anselin’s Local Indicators of Spatial Association (LISA) for Overall 
Cumulative NHL Incidence Data 
 
 
  
 
Figure 9. Anselin’s LISA for Cumulative NHL Incidence Data by Gender Strata 
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Figure 10. Anselin’s LISA for Cumulative NHL Incidence Data by SEER Tumor 
Classification Code 
 
  
  
 
Figure 11. Anselin’s LISA for Cumulative NHL Incidence Data by Gender and 
SEER Tumor Classification Code 
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 The hot spot analysis was conducted to identify areas of significant high or low 
spatial clustering of NHL incidence data using the Getis-Ord Gi* statistic. This differs 
from the Anselin’s LISA analysis in that each feature (e.g. census tract/buffer zone) and 
its neighboring features are compared to the average of all features on the map, 
whereas Anselin’s LISA only compares values from each feature to contiguous 
neighboring features. Hot and cold spots were mapped at the 99%, 95%, and 90% 
confidence limits. Results for overall data are depicted in Figure 12, and results by 
gender and SEER tumor classification are shown in Figures 13 and 14, respectively. 
There are interesting differences between the maps, as the profile of hot and cold spots 
is not necessarily uniform between overall data, data by gender, and data by SEER 
classification. As with the Anselin LISA tests, the overall data map shows the hot spots 
being located predominantly in the western and central parts of the state. When data is 
split by gender, the hot spots are more prominent for male cases, particularly the spots 
in the western region of the state, and the central region of the state corresponding to 
metro Louisville and Hardin County. When data is split by SEER classification, the 
western and metro Louisville hot spots become less prominent, and for extranodal NHL 
a hot spot emerges in Ashland-Boyd County. Collectively, these maps present further 
evidence of the need to utilize GWR in modeling the effect.  
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Figure 12. Hot Spot Analysis for Cumulative NHL Incidence Data – Overall 
  
48 
 
 
   
Figure 13. Hot Spot Analysis for Cumulative NHL Incidence Rates by Gender 
 
 
 
 
 
Figure 14. Hot Spot Analysis for Cumulative NHL Incidence Rates by SEER Tumor 
Classification Code 
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Regression Analysis 
The ordinary least squares (OLS) regression predicts the age-adjusted NHL 
cumulative incidence rates per 100,000 people using the two variables measuring 
exposure (<5km from nearest Superfund site, 5-10km from nearest Superfund site), 
along with Appalachian region (yes=1/no=0), and Beale Code (1 to 9) as independent 
variables. OLS modeling was performed for the cumulative incidence rate per 100,000 
people for total NHL, intranodal NHL (SEER code 33041), extranodal NHL (SEER code 
33042), and incidence rates for total NHL per 100,000 males and females. For each 
category, a base model was calculated with only the two exposure variables, and a full 
model which added the Appalachia and Beale Code variables. This resulted in a total of 
ten OLS models. Key outputs are summarized in Table 7. For the full list of OLS outputs 
and diagnostics, see Appendix 3. 
Specificially, the analysis showed that both exposure categories had significant 
and high coefficient values in all ten OLS models, with higher value in the category 
closer to the Superfund sites (Exposure <5km). Compared to the reference group 
(exposure beyond 10km), the <5km groups had significantly more NHL cases per 
100,000, ranging from 35.9 additional cases/100k in Model 9 (the base extranodal NHL 
model) to 157.92 additional cases/100k in Model 4 (the full male cases NHL model), 
when all other variables were held constant. Compared to the reference group, the 5-
10km exposure groups also had significantly more NHL cases/100,000 ranging from 
15.60 in Model 9 to 65.03 in Model 4.  
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Table 7: OLS Regression Modeling Results 
Model 
 
Variables Coefficient Std. Error Prob. Wald  
(Pr>2)  
Koenker (BP) 
(Pr>2) 
AIC Adj R-
squared 
Model 1:  
Overall Cumulative 
Incidence Rate (CIR) 
Intercept 261.26 8.43 <.001  
121.04 
(<.001) 
 
14.20  
(<.001) 
 
25137.29 
 
0.070 Exp <5km 113.60 10.76 <.001 
Exp 5-10km 50.82 8.98 <.001 
 
Model 2:  
Overall CIR 
Intercept 239.54 9.93 <.001  
 
125.89 
(<.001) 
 
 
20.08 
(<.001) 
 
 
25127.17 
 
 
0.076 
Appalachia -2.55 13.36 0.85 
Beale Code 5.80 1.93 0.003 
Exp <5km 123.82 11.60 <.001 
Exp 5-10km 57.19 9.11 <.001 
Model 3: 
Male CIR  
Intercept 292.56 9.70 <.001  
137.81 
(<.001) 
 
29.59 
 (<.001) 
 
25825.84 
 
0.082 Exp <5km 147.43 13.01 <.001 
Exp 5-10km 59.19 10.36 <.001 
 
Model 4:  
Male CIR 
Intercept 
Appalachia 
Beale Code 
Exp <5km 
Exp 5-10km 
269.53 
-23.89 
8.28 
157.92 
65.03 
11.61 
14.36 
2.38 
14.17 
10.52 
<.001 
0.10 
<.001 
<.001 
<.001 
 
 
141.04 
(<.001) 
 
 
47.17 
(<.001) 
 
 
25814.09 
 
 
0.089 
Model 5: 
Female CIR  
Intercept 
Exp <5km 
Exp 5-10km 
235.61 
85.05 
44.61 
11.30 
13.10 
11.80 
<.001 
<.001 
<.001 
 
50.01 
(<.001) 
 
4.20 
 (0.12) 
 
25938.92 
 
0.027 
 
Model 6:  
Female CIR 
 
Intercept 
Appalachia 
Beale Code 
Exp <5km 
Exp 5-10km 
215.19 
16.51 
3.56 
94.96 
51.42 
13.13 
18.60 
2.49 
13.91 
11.80 
<.001 
0.38 
0.15 
<.001 
<.001 
 
 
66.92 
(<.001) 
 
 
7.25 
(0.12) 
 
 
25933.66 
 
 
0.030 
Model 7: 
Intranodal CIR  
 
Intercept 
Exp <5km 
Exp 5-10km 
187.19 
77.70 
35.21 
6.91 
8.67 
7.28 
<.001 
<.001 
<.001 
 
89.27 
(<.001) 
 
7.81 
(0.02) 
 
24294.79 
 
0.052 
 
Model 8: 
Intranodal CIR  
 
Intercept 
Appalachia 
Beale Code 
Exp <5km 
Exp 5-10km 
173.59 
-6.91 
4.17 
84.01 
38.98 
8.27 
11.37 
1.57 
9.42 
7.39 
<.001 
0.54 
0.01 
<.001 
<.001 
 
 
92.62 
(<.001) 
 
 
12.30 
(0.02) 
 
 
24289.26 
 
 
0.055 
Model 9: 
 Extranodal CIR 
Intercept 
Exp <5km 
Exp 5-10km 
74.07 
35.90 
15.60 
2.91 
3.64 
3.27 
<.001 
<.001 
<.001 
 
107.84 
(<.001) 
 
39.73 
(<.001) 
 
21117.27 
 
0.057 
 
Model 10:  
Extranodal CIR 
 
Intercept 
Appalachia 
Beale Code 
Exp <5km 
Exp 5-10km 
65.95 
4.35 
1.64 
39.81 
18.21 
3.52 
4.17 
0.72 
3.95 
3.37 
<.001 
0.30 
0.02 
<.001 
<.001 
 
 
119.96 
(<.001) 
 
 
71.29 
(<.001) 
 
 
21104.74 
 
 
0.064 
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The Beale Code was also a significant predictor for the NHL cumulative 
incidence in most of the full models: the only full model in which it was not significant at 
p=0.05 was Model 6 (female cases, p=0.15). Being a resident of the Appalachia region 
was not a significant predictor in any of the OLS models; furthermore, the effect of living 
in the Appalachia region was not consistent across models, as the regression 
coefficients were negative in Models 2, 4, and 8 (the all-cases, male, and intranodal 
case models, respectively), and positive in Models 6 and 10 (female and extranodal 
case models, respectively). Full interpretation of the OLS model regression coefficients 
is provided below. 
 
Interpretation of OLS Model Coefficients: Model 4 
 For the OLS model which had the highest coefficient of determination (Model 4, 
with an adjusted R2 value of 0.089) and thus represented the best-fitting of the OLS 
models, the regression equation is:  
 18-year Cumulative Incidence of NHL /100,000 males = 269.53 - 23.89*Appalachia + 
8.28*BealeCode + 157.92*Exp<5km + 65.03*Exp5-10km. 
 
The reference group is made up of male cases who reside in Kentucky, outside the 
Appalachia region, and within an urban metro area with a population of one million or 
more (Beale Code = 0), and at least 10km away from all Superfund sites. Thus, the 
intercept shows that the overall NHL incidence rate (DV) for the reference group is 
269.53/100,000 males.  
The variable Appalachia measures the difference in the NHL cumulative 
incidence rate per 100,000 persons between the people residing in the Appalachia 
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region and the people residing elsewhere in the state. For males, the regression 
coefficient is -23.89 indicating that Appalachia region has on average lower NHL 
cumulative incidence rates than the rest of the state for males. The 18-year cumulative 
incidence rate for males was lower than in the reference group, and equaled (269.53 - 
23.89) = 245.64 cases/100,000 males. Thus, the regression coefficient (b=-23.89, 
p=.010) shows that the Appalachian region in Kentucky has on average an overall NHL 
cumulative incidence rate for males that is 23.89 cases/100,000 lower than the non-
Appalachian Kentucky, when all other variables in the model are held constant; 
however, this regression coefficient was not significantly different from zero, and can be 
approximated to be zero in the calculations. In addition, the Appalachia variable was not 
significantly different from zero in any of the other full OLS models, and had a positive 
coefficient value in the female and extranodal case models (Models 6 and 10, 
respectively). 
The variable Beale Code measures urbanicity and rurality. Values range from 0 
to 9; the smaller the code value, the more urban an area. The Beale Code value of 0 is 
assigned for residence within a metropolitan area of population 1,000,000 or more, and 
Beale Code 9 is assigned for residence within a rural area (population <2500) not 
adjacent to any urban areas (population >2500). The regression coefficient (b=8.28, 
p=<.001) in the best-fitting OLS model (Model 4) shows that as the Beale Code 
increases by 1 unit, the overall cumulative male NHL incidence rate increases by 8.28 
NHL cases/100,000, when all other variables in the model are held constant; thus, the 
more rural an area is the higher the overall cumulative NHL incidence rate. For the most 
rural areas, where Beale Code = 9, the incidence rate numerator equals [269.53 + 
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(8.28*9)] = 344.05 NHL cases/100,000, an increase of 74.52 cases per 100,000 males 
above the rate for the reference group. The most urban Beale Code value in the study 
basin was 1, as there were no central metropolitan areas with population >1 million in 
Kentucky. When Beale Code = 1, the incidence rate numerator equals [269.53 + 
(8.28*1)] = 277.81 NHL cases/100,000, an increase of 8.28 cases/100,000 males above 
the reference group. The Beale Code regression coefficient was significantly different 
from zero (p<.05) in the best-fitting model and in all other OLS models except for the 
female cases model (Model 6, p=0.15). 
The regression coefficients for the exposure variables show the difference in the 
NHL cumulative incidence rate per 100,000 between the reference group and cases 
who reside within 5km from one or more Superfund sites (Exp<5km), or more than 5km 
away but within 10km of one or more Superfund sites (Exp5-10km). For the best-fitting 
OLS model (Model 4), when examining residence within 5km of Superfund sites 
(b=157.92, p<.001), the NHL incidence rate per 100,000 males equals (269.53 + 
157.92) = 427.45 NHL cases/100,000. For residence within 5km and 10km of one or 
more Superfund sites (b=50.82, p<.001), the male NHL cumulative incidence rate 
equals (269.53+ 65.03) = 334.56 NHL cases/100,000. Both coefficients are significantly 
different from zero, but the Exp<5km exposure variable has a much larger effect on 
NHL incidence rates. 
 
Interpretation of OLS Model Coefficients: Model 2 
For all the OLS models, the exposure variables have significant and positive 
regression coefficients (p<.001), with the <5km variables having higher values than the 
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5-10km variables. For Model 2, which is the best-fitting model that includes all NHL 
cases in Kentucky from 1995-2012, rather than subdividing by gender or SEER type, 
the regression equation is:  
 
18-year Cumulative Incidence of Intranodal NHL /100,000 = 239.54 +  
(-2.55)*Appalachia + 5.80* Beale Code + 123.82*Exp<5km + 57.19*Exp5-10km. 
 
The reference group is made up of NHL cases who do not reside in the Appalachia 
region, and reside within an urban metro area with a population of one million or more 
(Beale Code = 0), and at least 10km away from all Superfund sites. Thus, the intercept 
shows that the cumulative NHL incidence rate per 100,000 people (DV) for the 
reference group is 239.54.  
As with Model 4, the coefficient Appalachia in Model 2 is negative but not 
significant (b=-2.55, p=.85). The incidence rate was lower than in the reference group, 
and equaled (239.54 – 2.55) = 236.99 cumulative NHL cases/100,000, or 2.55 
cases/100,000 lower than non-Appalachian Kentucky residents, when all other variables 
in the model are held constant. 
The Beale Code coefficient is positive and significant in Model 2 (b=5.80, 
p=.003). For the most rural areas (Beale Code = 9), the cumulative intranodal NHL 
incidence rate is [239.54 + (5.80*9)] = 291.74 cases/100,000, an increase of 52.2 
cases/100,000 above the reference group. For the most urban areas in the study basin 
(Beale Code = 1), the increase above the reference group is 5.80 cases/100,000, for a 
total of 245.34 cases/100,000, when all other variables are held constant. 
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Both of the exposure variables are positive and highly significant in Model 2, but 
the Exp<5km variable has a much larger effect on cumulative NHL incidence rates. For 
residence within 5km of Superfund sites (b=123.82, p<.001), the cumulative NHL 
incidence rate per 100,000 equals (239.54 + 123.82) = 363.36 NHL cases/100,000. For 
residence >5km but within 10km of one or more Superfund sites (b=57.19, p<.001), 
incidence rate equals (239.54 + 57.19) = 296.73 NHL cases/100,000. 
 
Other OLS Models 
The remaining OLS models (which include every base model, plus the full 
models that separately evaluated female, intranodal, and extranodal cases) had lower 
coefficients of determination compared to the best-fitting models, indicating a poorer fit 
around the regression line. None of the OLS models in Table 7 explained a large 
amount of the variability around the fitted regression line, with the coefficients of 
determination ranging from 2.7% to 8.9% (Appendix 3). The OLS models had 
acceptable levels for the variance inflation coefficients, but significant Koenker (BP) 
statistics in almost all models indicate non-consistent relationships between the 
dependent and independent variables (non-stationarity); thus, a geographically 
weighted regression (GWR) is more likely to be appropriate than the OLS models. 
 
Geographically Weighted Regression 
GWR was the final stage of analysis. As with OLS models, the explanatory 
variables included the two exposure groups, Appalachia region (1=yes, 0=no), and 
Beale Code (numeric code, higher for rural areas). Adaptive kernel density estimation 
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was utilized, along with the Akaike Information Criterion (corrected) to estimate 
bandwidth.  
Base models (exposure groups only) and full models (exposure groups plus 
Appalachia plus Beale Code) were generated for five different age-adjusted NHL 
incidence rates: all cases, male cases, female cases, intranodal cases, and extranodal 
cases, for a total of ten GWR models. These ten models were labeled as Models 11 
through 20, and the outputs for each of these GWR models are listed in Table 8.  
The Akaike’s Information Criterion (AIC) values were compared between each 
GWR models and their analagous OLS models from Table 7. For example, Model 11 in 
GWR was compared to Model 1 in OLS, since both used the same subset of data and 
predictor variables. In each case, for all ten model pairs, the AIC values were lower for 
the GWR models compared to their OLS counterparts, indicating that the GWR models 
were a better fit for the data. Comparing the adjusted R-squared values from the OLS 
models (Table 7) to the unadjusted R-squared values in GWR models (Table 8) also 
makes it apparent that the GWR models represent a better fit around the regression 
line, and explain a larger percentage of the variability. For the OLS models, the 
coefficients of determination ranged from 2.7% to 8.9%, whereas for the GWR models, 
these ranged from 6.6% to 24.6%.  Adjusted R-squared values should not be used to 
make inferences about the proportion of variance explained by GWR models, since 
these values are sensitive to bandwidths used to calculate degrees of freedom150. The 
R-squared results are in agreement with the AIC and confirm that, when looking at all 
NHL cases in the data set, the best-fitting model of the set is Model 11 (the GWR base 
model), which explains approximately 23.1% of the variability in the overall NHL 
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incidence rate. When looking at subsets of NHL cases, the best-fitting model is Model 
13 (the GWR base model for males), which explains approximately 24.6% of the 
variability in NHL incidence rate for male subjects, and represents the overall best-fitting 
model of all GWR and OLS models.  
 
Table 8: GWR Modeling Results 
Model Variables Number of 
Neighbors  
Sigma Akaike’s Information 
Criterion 
R-square 
Model 11:  
Overall CIR 
Exp <5km 
Exp 5-10km 
 
241 
 
155.81 
 
24893.80 
 
0.231 
 
Model 12:  
Overall CIR 
 
Appalachia 
Beale Code 
Exp <5km 
Exp 5-10km 
 
 
834 
 
 
163.24 
 
 
25047.16 
 
 
0.134 
Model 13:  
Male CIR 
Exp <5km 
Exp 5-10km 
 
241 
 
185.75 
 
25569.11 
 
0.246 
 
Model 14:  
Male CIR 
 
Appalachia 
Beale Code 
Exp <5km 
Exp 5-10km 
 
 
834 
 
 
194.50 
 
 
25720.15 
 
 
0.152 
Model 15:  
Female CIR 
Exp <5km 
Exp 5-10km 
 
241 
 
196.84 
 
25791.99 
 
0.154 
 
Model 16:  
Female CIR 
 
Appalachia 
Beale Code 
Exp <5km 
Exp 5-10km 
 
 
836 
 
 
204.10 
 
 
25905.25 
 
 
0.066 
Model 17:  
Intranodal CIR 
Exp <5km 
Exp 5-10km 
 
241 
 
125.65 
 
24067.25 
 
0.209 
 
Model 18:  
Intranodal CIR 
Appalachia 
Beale Code 
Exp <5km 
Exp 5-10km 
 
834 
 
131.76 
 
24224.08 
 
0.107 
Model 19:  
Extranodal CIR 
Exp <5km 
Exp 5-10km 
 
241 
 
55.10 
 
20900.00 
 
0.210 
 
Model 20:  
Extranodal CIR 
Appalachia 
Beale Code 
Exp <5km 
Exp 5-10km 
 
 
834 
 
 
57.01 
 
 
21005.11 
 
 
0.132 
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When non-stationarity is present in the data, GWR is designed to allow local 
variation in the explanatory variable coefficients. For Model 11, the all-cases best-fitting 
GWR base model, the coefficient values for the Exp <5km and Exp 5-10km variables 
are listed and depicted in Figure 15. The mean value for the Exp <5km coefficient was 
120.67 (standard deviation 84.48, t-statistic=62.59, p<.001), and for Exp 5-10km it was 
45.94 (standard deviation 66.35, t-statistic=30.37, p<.001). Therefore, the average 
increase in cumulative NHL incidence rate per 100k above the baseline condition (Exp 
>10km) in areas within 5km of Superfund sites in Kentucky was 121 cases/100k, and in 
areas between 5km and 10km from Superfund sites it was 46 cases/100k. 
 
Figure 15: GWR Coefficient Values for All-Cases Best-Fitting Model 
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For the overall best-fitting model (Model 13, the GWR base model for all NHL 
cases in male subjects), the coefficient values for the Exp <5km and Exp 5-10km 
variables are listed and depicted in Figure 16. The mean value for the Exp <5km 
coefficient was 159.93 (standard deviation 104.01, t-statistic=67.39, p<.001), and for 
Exp 5-10km it was 58.59 (standard deviation 69.70, t-statistic=36.84, p<.001). 
Residence within 5km of a Superfund site in Kentucky increased the cumulative NHL 
cases per 100,000 males above the baseline by 160, and residence 5-10km away 
increased cases/100,000 males by 59, when all other variables were held constant.  
 
 
Figure 16: GWR Coefficient Values for Male Cases (and Overall) Best-Fitting 
Model 
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The coefficient values for the best-fitting models that examined only female, 
intranodal, and extranodal NHL cases are depicted below in Figures 17 through 19. 
Only the “base” models are shown, since in each case the “full” models had higher AIC 
values and lower R2 values. In all three models, both of the exposure variables were 
positive and significantly different than zero.  
Figure 17 shows that, for female cases (Model 15), the mean value for the Exp 
<5km coefficient was 85.86 (standard deviation 88.33, t-statistic=42.60, p<.001), and for 
Exp 5-10km it was 33.95 (standard deviation 80.67, t-statistic=18.45, p<.001). Figure 18 
shows that, for intranodal cases (Model 17), the mean value for the Exp <5km 
coefficient was 80.95 (standard deviation 67.01, t-statistic=52.95, p<.001), and for Exp 
5-10km it was 30.04 (standard deviation 55.60, t-statistic=23.68, p<.001). Figure 19 
shows that, for extranodal cases (Model 19), the mean value for the Exp <5km 
coefficient was 39.71 (standard deviation 24.84, t-statistic=70.07, p<.001), and for Exp 
5-10km it was 15.90 (standard deviation 25.15, t-statistic=27.71, p<.001). The results 
depicted in Figures 15 through 19 demonstrate that, in both the overall NHL data set 
and subsets of data by gender and SEER tumor classification, residential proximity of 
less than 5km from the nearest Superfund site, or between 5km and 10km from the 
nearest Superfund site, is a significant predictor of NHL incidence.  
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Figure 17: GWR Coefficient Values for Female Cases Best-Fitting Model 
 
 
 
Figure 18: GWR Coefficient Values for Intranodal Cases Best-Fitting Model 
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Figure 19: GWR Coefficient Values for Extranodal Cases Best-Fitting Model 
 
The mapped outputs of the GWR model residuals are depicted below. Figure 20 
shows the residuals for Model 11 (the all-cases base model), Figure 21 shows residuals 
for Model 13 (male cases base model, and the overall best-fitting model) and Model 15 
(female cases), and Figure 22 shows the residuals for intranodal and extranodal NHL 
base models (Models 17 and 19, respectively). The GWR residuals for “full” models 
(which include Appalachia and Beale Code) are not shown because in every instance 
they had higher AIC values and lower R2 values than their base counterparts.  
The patterns and magnitudes of residuals by census tract, 5-10km buffer zone, 
and 5km buffer zone depicted in Figures 20 through 22 are not surprising, given that the 
best-fitting GWR model still only explained 24.6% of the variability in the dependent 
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variable. An additional 75.4% or more, depending on the particular model, is therefore 
not explained, and these errors between the observed incidence rates and the rates 
predicted by models do not show any readily apparent pattern in any model. It can be 
noted that in all models, there appear to be more areas of “high” standardized residuals 
than “low” standardized residuals. The highest magnitude areas, where the observed 
incidence rates exceed the predicted rates by more than 2.5 standard deviations, are 
most prominent in the central and western areas of Kentucky.  Low areas, where the 
observed incidence rates are lower than the predicted rates, are randomly scattered 
throughout the state. Across all residual maps, the tracts/buffer zones with high and low 
residual values tend to hold up across all models, though the color shading might 
change slightly to indicate lower-magnitude residuals in the 1.5 to 2.5 standard 
deviations range. 
The combination of standardized GWR regression residual diagrams and the 
adjusted R2 values strongly suggest that there are likely other explanatory variables 
which might contribute to NHL incidence, and which we were unable to capture in the 
current investigation. However, the data collected and analyzed in the present 
investigation supported the hypothesis that residential proximity to Superfund sites in 
Kentucky is a significant factor in elevated incidence of non-Hodgkin’s lymphoma. 
These results are similar to those documented in Georgia by investigators who looked 
at NHL risk and residential proximity to areas where benzene was released and 
documented in the EPA Toxics Release Inventory151.  
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Figure 20. Geographically Weighted Regression Residuals, Cumulative NHL 
Incidence Data for All Cases, Kentucky, 1995-2012 
  
Model 11 
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Figure 21. Geographically Weighted Regression Residuals, Cumulative NHL 
Incidence Data for Male and Female Cases, Kentucky, 1995-2012 
Model 13 
Model 15 
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Figure 22. Geographically Weighted Regression Residuals, Cumulative NHL 
Incidence Data for Intranodal and Extranodal Cases, Kentucky, 1995-2012 
Model 17 
Model 19 
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CHAPTER 5 
IMPLICATIONS FOR PUBLIC HEALTH 
 
 
Non-Hodgkin’s lymphoma is one of the most prevalent cancers in Kentucky, the 
United States, and many Western countries. Incidence and prevalence rates both 
increased markedly during the latter half of the 20th Century, in a time-lagged 
concurrency with the marked increase in the manufacture, use, and disposal of 
chemical products, which strongly links the two phenomena together. Research is 
ongoing to discover ways to diagnose, treat, and prevent NHL, and the current five-year 
survival rate following NHL diagnosis in the United States is 69%152.  This research is 
urgently needed, because persons are more susceptible to NHL as they age, and 
demographic trends point toward the aging of the U.S. population between 2015 and 
2050153.  
The present study investigated whether residential proximity to NPL/Superfund 
sites in Kentucky could be at least partially responsible for the increasing and then 
plateauing incidence of NHL from the mid-20th Century to the present. Data 
representing all cases of NHL reported to the Kentucky Cancer Registry between 1995 
and 2012 were acquired and cleaned. This data was used to calculate 18-year 
incidence rates for NHL at the 2010 U.S. Census tract level. Because NHL risk is not 
evenly distributed across the lifespan, incidence data was age-adjusted using a 
standard population from the 2000 U.S. Census. These age-adjusted NHL rates were 
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the outcome data, which were evaluated through both conventional and geospatial 
statistical methods. 
The total number of cases of NHL in Kentucky showed an upward trend from 
1995 to 2012, which was more pronounced in non-white subjects. Bivariate analysis 
revealed that non-white cases, and cases with no prior known family history of NHL, 
were significantly more likely to live within 5km of Superfund sites. Rates were 
significantly higher in the exposed (10km or less) regions than in the unexposed 
regions, across every outcome stratum except intranodal cases in females. Rates of 
NHL were not higher in the Appalachian (eastern and southern) regions of Kentucky, 
making NHL unlike many other forms of cancer which show clustering or higher rates in 
Appalachian compared to non-Appalachian regions of the United States154-157.  
The outcome data was spatially autocorrelated, clustered, and exhibited non-
stationarity, all indicators that geographically weighted regression (GWR) techniques 
would be necessary. Both Ordinary Least Squares (global) regression and localized 
GWR showed that NHL rates were significantly elevated in geographic areas within 5km 
of Superfund sites, and in areas between 5km and 10km of Superfund sites, when 
controlling for covariates which were significant in bivariate analysis. The effect size was 
greater in the population with more exposure (<5km). Therefore, the investigation 
supported the hypothesis that closer residential proximity to Superfund sites in Kentucky 
was a significant factor in NHL risk. 
The results from the present study point to disparities in rate of NHL across 
Kentucky due to living near recognized areas of environmental toxicity. These areas, by 
virtue of being on the U.S. EPA Superfund list, were formally designated as needing 
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evaluation and some degree of clean-up. The results raise questions about 
environmental justice. Persons in disadvantaged positions often do not have the political 
or economic power to organize resistance to nearby hazardous or noxious land uses, 
whereas more affluent regions are able to mount NIMBY (Not in my Backyard) 
responses and keep them away158. Unequal burdens of exposure and outcome along 
racial, ethnic, and socioeconomic lines are often the product of facility siting decisions 
that make initial economic sense due to lower property costs, lower required 
compensation levels for adjacent landowners, or a desire to reduce local levels of 
unemployment or underemployment159. While multivariate analysis by race could not be 
conducted in the present study due to the small proportion of non-white NHL cases, it 
must be noted that non-white cases were significantly more likely to live within 5km of 
Superfund sites compared to white cases. This is consistent with patterns that exist 
nationwide, particularly among African-Americans160.  
Are persons who live closer to Superfund sites, and have higher rates of NHL, 
actually exposed to higher levels of contaminants which can trigger NHL? The nature 
and pathways of exposure to potentially hazardous substances from Superfund sites in 
Kentucky are not fully known, but reasonable hypotheses can be drawn from limited 
available data. Of the twenty Kentucky sites that scored highest in the EPA’s Hazard 
Ranking System and were thus on the National Priorities List, a majority had one or 
more on-site contaminants known or suspected to increase NHL incidence. The most 
commonly found of these contaminants were benzene, lead, PCBs, cadmium, 
trichloroethylene, organochlorines other than PCBs, and perchloroethylene143. The most 
likely exposure pathways in the current context would be through ground water or 
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surface water, whereas offsite exposure through air or contaminated soil would probably 
be limited. Air exposures from Superfund sites are generally due to gaseous pollutants, 
secondary pollutants generated by reactions, or wind erosion from contaminants 
deposited onto surfaces, which are not as likely with the sites in the present study. 
While contaminated soil itself does not migrate off-site, plumes of pollutants can migrate 
with the water table and move laterally through soils.  
 
Recommendations 
Persons who live close to Superfund sites in Kentucky appear to have a 
significantly higher NHL risk. As with many public health issues, there are a variety of 
target areas where efforts can be directed. These will be described below, starting with 
the upstream (distal, societal) factors, then working down to community, neighborhood, 
and individual-level approaches. 
Upstream approaches that prevent the problem from occurring can be a possible 
target, but these approaches are often expensive, beyond the scope of traditional public 
health practice, and require extensive inter-agency involvement. For example, 
mandatory evictions and buyouts of residences near the most contaminated sites can 
prevent residential exposure, and have occurred in areas such as Niagara Falls, NY161, 
Times Beach, MO162, and Houston, TX163. However, this can lead to numerous legal 
and ethical challenges. Land values might be depressed due to the adjacent activities 
that necessitated the buyouts, or persons might resist buyouts and leaving their 
ancestral domiciles. It is not likely that the U.S. EPA or any governmental agency with 
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eminent domain powers would deem it feasible or desirable to evict/buyout residents 
living near Superfund sites to reduce NHL risk, based on current evidence. 
American environmental policy and siting decisions are slowly transitioning from 
NIMBY to “Not in Anyone’s Backyard” as the knowledge of both the direct (toxicity, 
illness, reduced property values) and indirect (stress, allostatic load) effects of 
residential proximity to hazardous materials and processes become more known164. In 
the United States, the burden for absorbing the externality of pollution has shifted from 
the surrounding community to the generating entities through federal environmental 
laws such as SARA Title III (also known as the Emergency Planning and Community 
Right-to-Know Act), the Hazardous and Solid Waste Amendments of RCRA, and the 
Ground Water Rule. These efforts have resulted in improvements to new and existing 
hazardous sites, but vigilant surveillance from both regulatory and community entities is 
still necessary to ensure that environmental outcomes are fair and just. Upstream 
interventions, education, and advocacy could improve justice in future siting, monitoring, 
clean-up, and closure activities, but would be slow to impact those currently affected.  
Another factor curtailing the ability to clean existing sites and reduce possible 
NHL risk is that the actual “Superfund” from CERCLA no longer exists. The tax on 
petrochemical industries that created the fund to perform cleanups ceased in 1995 
following significant pressure on the Legislature, and the fund officially went bankrupt in 
2003165. Since that time, Superfund site activities have been funded by annual 
appropriations to the EPA, which have been stagnant or declining for years in a highly 
competitive environment for Federal dollars166. While there has been an effort to 
reinstate the Superfund tax during the Obama administration166, as of 2015 it has still 
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not been enacted and is not likely to be considered soon. Unless grassroots advocacy 
can mobilize a groundswell of support from citizens to bolster the Superfund program, 
the current slow pace of assessment and cleanup will continue, and persons who live 
near contaminated sites will continue to be at higher risk for NHL and other negative 
effects to health and well-being. To the extent that public health can advocate for those 
who share unequal health burdens due to hazardous sites, and for increased funding for 
CERCLA and other beneficial programs that tackle the problem upstream, it should do 
so. However, in the present climate, it is more prudent to apply public health efforts 
downstream at the regional, community, or individual level.  
Research on the potential causal factors of NHL has already provided several 
interesting clues, but must continue until definitive linkages are found. Community and 
regional research on NHL incidence is also critical. The present study provides an 
important example of possible causal linkage between hazardous waste site exposures 
and NHL; however, studies similar to this one should be replicated in other settings, 
particulary in areas with greater racial and ethnic diversity. Also, more research is 
needed to bring exposure pathways into clearer view so that exposure misclassification 
is minimized. Water would be the most likely media for transfer of toxicants from 
Superfund sites to adjacent residential areas, with soil and air as less likely paths. 
Tracking drinking-water sources for NHL cases and controls, and comparing levels of 
possible NHL-triggering toxicants in surface water and groundwater samples, would be 
an important next step, as would examination of groundwater hydrography data to know 
which direction(s) from the site would be most likely affected. For sites where 
soil/surface contamination is the primary hazard, examining wind-rose data might show 
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where airborne/dustborne contaminants are most likely to have an impact. 
Misclassification due to residential mobility could not be evaluated in the present study, 
as only the residential coordinates at the time of diagnosis were available. Studies that 
are able to include model components for residential change would be helpful, and have 
shown promise167.  
Community and individual level efforts at education and screening are critical, 
even though these are downstream actions that do not directly address the upstream 
factors driving NHL incidence. Education and awareness campaigns about NHL, its risk 
factors, and symptoms could lead to earlier diagnosis and better outcomes in affected 
communities. At the present time, there is not a simple, inexpensive screening test for 
NHL that makes it amenable to a “mobile clinic” setting like other cancers such as 
breast and colon. Early detection relies on techniques such as lymph node biopsy, 
blood cell chemistry and morphology tests, or imaging scans which can detect not just 
NHL but other hematological malignancies168. Encouraging persons who score high on 
risk factor and symptom surveys for NHL to seek medical advice and screening could 
save lives and improve outcomes, if combined with funding for tests and specialized 
medical knowledge in the communities most affected by NHL. Medical research should 
continue to investigate simple, low-cost, sensitive and specific methods for detecting 
NHL, as it will most likely continue to be a cancer of high-incidence as the population 
ages.  
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Summary 
Non-Hodgkin’s lymphoma (NHL) incidence in the United States and many other 
Western nations increased throughout the 20th Century, in a pattern that suggests 
greater exposure to chemicals might be a causal factor. Mechanistic research suggests 
many pathways by which chemicals and xenobiotics can trigger NHL. The present study 
demonstrated that residential proximity to hazardous waste sites in Kentucky was a 
significant risk factor for NHL. Additional research, advocacy, and education should 
focus on mechanisms of NHL incidence, replicating the present study in other contexts 
and with monitoring data, addressing upstream factors that lead to unequal burdens of 
hazardous material exposures and NHL, downstream education and awareness, and 
better methods for NHL screening and early detection.  
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APPENDIX 2: EXPLORATORY REGRESSION OUTPUT 
 
****************************************************************************** 
Choose 1 of 22 Summary 
    Highest Adjusted R‐Squared Results    
AdjR2     AICc   JB K(BP)  VIF   SA   Model     
 0.06 25165.51 0.00  0.77 1.00 0.00  +EXP5KM*** 
 0.00 25271.59 0.00  0.17 1.00 0.00  +H4**      
 0.00 25273.79 0.00  0.89 1.00 0.00  +H10*      
       Passing Models        
AdjR2 AICc JB K(BP) VIF SA   Model 
****************************************************************************** 
Choose 2 of 22 Summary 
          Highest Adjusted R‐Squared Results           
AdjR2     AICc   JB K(BP)  VIF   SA   Model                  
 0.07 25137.29 0.00  0.00 1.28 0.00  +EXP5KM***  +EXP5_10*** 
 0.06 25159.76 0.00  0.49 1.01 0.00  +H17***  +EXP5KM***     
 0.06 25160.08 0.00  0.62 1.01 0.00  +H14***  +EXP5KM***     
       Passing Models        
AdjR2 AICc JB K(BP) VIF SA   Model 
****************************************************************************** 
Choose 3 of 22 Summary 
                 Highest Adjusted R‐Squared Results                 
AdjR2     AICc   JB K(BP)  VIF   SA   Model                               
 0.08 25125.05 0.00  0.00 1.32 0.00  +H17***  +EXP5KM***  +EXP5_10***     
 0.08 25125.22 0.00  0.00 1.39 0.00  +EXP5KM***  +EXP5_10***  +BEALE_R*** 
 0.07 25129.02 0.00  0.00 1.36 0.00  ‐H3***  +EXP5KM***  +EXP5_10***      
       Passing Models        
AdjR2 AICc JB K(BP) VIF SA   Model 
****************************************************************************** 
Choose 4 of 22 Summary 
                     Highest Adjusted R‐Squared Results                     
AdjR2     AICc   JB K(BP)  VIF   SA   Model                                       
 0.08 25122.72 0.00  0.00 1.39 0.00  +H14**  +EXP5KM***  +EXP5_10***  +BEALE_R*** 
 0.08 25122.73 0.00  0.00 1.32 0.00  +H4**  +H17***  +EXP5KM***  +EXP5_10***      
 0.08 25122.77 0.00  0.00 1.51 0.00  +H17*  +EXP5KM***  +EXP5_10***  +BEALE_R**   
       Passing Models        
AdjR2 AICc JB K(BP) VIF SA   Model 
****************************************************************************** 
Choose 5 of 22 Summary 
                       Highest Adjusted R‐Squared Results                        
AdjR2     AICc   JB K(BP)  VIF   SA   Model                                            
 0.08 25119.56 0.00  0.00 1.38 0.00  +H4***  ‐H11***  +H17***  +EXP5KM***  +EXP5_10*** 
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 0.08 25121.71 0.00  0.00 1.56 0.00  +H4*  +H17*  +EXP5KM***  +EXP5_10***  +BEALE_R*   
 0.08 25121.94 0.00  0.00 1.39 0.00  +H4  +H14**  +EXP5KM***  +EXP5_10***  +BEALE_R*** 
       Passing Models        
AdjR2 AICc JB K(BP) VIF SA   Model 
****************************************************************************** 
************** Exploratory Regression Global Summary (R_CT_ADJ) ************** 
              Percentage of Search Criteria Passed              
                   Search Criterion Cutoff Trials # Passed % Passed 
             Min Adjusted R‐Squared > 0.50  24509        0     0.00 
            Max Coefficient p‐value < 0.05  24509       86     0.35 
                      Max VIF Value < 7.50  24509    22413    91.45 
            Min Jarque‐Bera p‐value > 0.10  24509        0     0.00 
Min Spatial Autocorrelation p‐value > 0.10     18        0     0.00 
‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐ 
     Summary of Variable Significance     
Variable % Significant % Negative % Positive 
EXP5KM          100.00       0.00     100.00 
H4               50.39       0.00     100.00 
H5               36.12      85.02      14.98 
H2               25.26      14.62      85.38 
H17              24.22       3.32      96.68 
EXP5_10          19.48      76.30      23.70 
H14              18.84       0.00     100.00 
H9               15.10       0.24      99.76 
H10              15.10       0.24      99.76 
H3               13.57      72.24      27.76 
H13              12.61       0.26      99.74 
BEALE_R          11.20      45.77      54.23 
H8                7.97      83.39      16.61 
H1                4.68      58.18      41.82 
H7                4.68      58.18      41.82 
H11               2.50      36.29      63.71 
H15               2.39      35.82      64.18 
P77               0.00      14.79      85.21 
H12               0.00       0.09      99.91 
H16               0.00       0.59      99.41 
APPAL             0.00      85.54      14.46 
H6            ‐‐‐‐‐‐‐‐   ‐‐‐‐‐‐‐‐   ‐‐‐‐‐‐‐‐ 
‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐ 
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                                                       Summary of Multicollinearity*                                                         
Variable      VIF Violations Covariates                                                                                                         
P77          2.83     0      ‐‐‐‐‐‐‐‐                                                                                                           
H1         412.67    679     H8 (50.22), H15 (2.07)                                                                                             
H2         624.13    105     H8 (7.77), H5 (7.77), H15 (0.15)                                                                                   
H3         247.02     13     H8 (0.96), H4 (0.96), H5 (0.96)                                                                                    
H4         115.62     13     H3 (0.96), H8 (0.96), H5 (0.96)                                                                                    
H5         489.10    118     H8 (8.73), H2 (7.77), H3 (0.96), H4 (0.96), H15 (0.15)                                                    
H6       ‐‐‐‐‐‐‐‐    ALL     INTERCEPT (100.00)                                                                                                 
H7         412.67    679     H8 (50.22), H15 (2.07)                                                                                             
H8         361.82    1476    H1 (50.22), H7 (50.22), H5 (8.73), H2 (7.77), H15 (4.29), H3 (0.96), H4 (0.96)         
H9         393.81    310     H15 (15.01), H17 (0.44), H11 (0.15), H13 (0.07)                                                              
H10        393.81    310     H15 (15.01), H17 (0.44), H11 (0.15), H13 (0.07)                                                            
H11         37.42     4      H15 (0.30), H10 (0.15), H9 (0.15), H13 (0.15), H17 (0.15)                                                
H12          1.38     0      ‐‐‐‐‐‐‐‐                                                                                                           
H13          9.01     2      H11 (0.15), H15 (0.15), H17 (0.15), H10 (0.07), H9 (0.07)                                                 
H14          1.65     0      ‐‐‐‐‐‐‐‐                                                                                                           
H15        226.36    464     H9 (15.01), H10 (15.01), H8 (4.29), H1 (2.07), H7 (2.07), H17 (0.89), H11 (0.30), 
H2 (0.15), H13 (0.15), H5 (0.15) 
H16          1.10     0      ‐‐‐‐‐‐‐‐                                                                                                           
H17         44.50     12     H15 (0.89), H10 (0.44), H9 (0.44), H11 (0.15), H13 (0.15)                                              
EXP5KM       1.45     0      ‐‐‐‐‐‐‐‐                                                                                                           
EXP5_10      1.35     0      ‐‐‐‐‐‐‐‐                                                                                                           
APPAL        1.48     0      ‐‐‐‐‐‐‐‐                                                                                                           
BEALE_R      2.31     0      ‐‐‐‐‐‐‐‐                                                                                                           
* At least one model failed to solve due to perfect multicollinearity. 
Please review the warning messages for further information. 
‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐ 
             Summary of Residual Normality (JB)              
      JB     AdjR2         AICc    K(BP)      VIF       SA   Model 
0.000000  0.000557 25274.824611 0.030913 1.000000 0.000000  +H2    
0.000000 ‐0.000136 25276.155398 0.159671 1.000000 0.000000  +H1    
0.000000  0.000288 25275.340849 0.158239 1.000000 0.000000  +P77   
‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐ 
        Summary of Residual Spatial Autocorrelation (SA)        
      SA    AdjR2         AICc       JB    K(BP)      VIF   Model     
0.000000 0.000557 25274.824611 0.000000 0.030913 1.000000  +H2        
0.000000 0.002236 25271.593816 0.000000 0.171381 1.000000  +H4**      
0.000000 0.055842 25165.510295 0.000000 0.771149 1.000000  +EXP5KM*** 
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‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐ 
Table Abbreviations 
AdjR2 Adjusted R‐Squared                                      
AICc  Akaike's Information Criterion                          
JB    Jarque‐Bera p‐value                                     
K(BP) Koenker (BP) Statistic p‐value                          
VIF   Max Variance Inflation Factor                           
SA    Global Moran's I p‐value                                
Model Variable sign (+/‐)                                     
Model Variable significance (* = 0.10, ** = 0.05, *** = 0.01) 
‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐ 
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APPENDIX 3: OLS OUTPUTS AND DIAGNOSTICS  
 
Model 1: Base Model for all NHL 
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Model 2: Full Model for all NHL 
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Model 3: Base Model for Male NHL 
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Model 4: Full Model for Male NHL 
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Model 5: Base Model for Female NHL 
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Model 6: Full Model for Female NHL 
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Model 7: Base Model for Intranodal NHL 
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Model 8: Full Model for Intranodal NHL 
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Model 9: Base Model for Extranodal NHL 
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Model 10: Full Model for Extranodal NHL 
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